PAPER De Simone A, Naldi M, Tedesco D, Bartolini M, Davani L, Andrisano V

Advanced analytical methodologies in Alzheimer's disease drug discovery.

J Pharm Biomed Anal. 2019 Sep 29;178:112899. PubMed: 31606562

Christina Appleton

Christina Appleton Psychological Services
Laguna Hills, United States

Thy1-αSyn “Line 61” Mouse

RESEARCH MODELS Summary The Thy1-αSyn mouse model, a.k.a. Line 61, overexpresses human α-synuclein under the Thy1 promoter (Rockenstein et al., 2002). It is one of the most extensively characterized animal models of Parkinson’s disease (PD), and reproduces several ...

Domagoj Barać

PVT
Zagreb, Croatia

Silvia Fossati

Temple University
Philadelphia, United States

Sally Wilson

Ascension
Wichita, United States

Junior Specialist

JOB 2019-10-14 Employer University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders Principal Investigator Mathew Blurton-Jones Contact Please submit a letter of interest, curriculum vitae which should include a record of research ...

Wiktoria Jozefowska

University of Bath
Bath, United Kingdom

Edgar Cortes

PAPER Kabir MT, Abu Sufian M, Uddin MS, Begum MM, Akhter S, Islam A, Mathew B, Islam MS, Amran MS, Md Ashraf G

NMDA Receptor Antagonists: Repositioning of Memantine as Multitargeting Agent for Alzheimer's Therapy.

Curr Pharm Des. 2019 Oct 10; PubMed: 31604413

PAPER Fyfe I

Prodromal frontotemporal dementia associated with changes in ventricular volume.

Nat Rev Neurol. 2019 Oct 11; PubMed: 31605033

PAPER Prediger RD, Schamne MG, Sampaio TB, Moreira EL, Rial D

Animal models of olfactory dysfunction in neurodegenerative diseases.

Handb Clin Neurol. 2019;164:431-452. PubMed: 31604561

PAPER Karki R, Kodamullil AT, Hoyt CT, Hofmann-Apitius M

Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.

BMC Bioinformatics. 2019 Oct 11;20(1):494. PubMed: 31604427

PAPER Michno W, Wehrli P, Meier S, Sehlin D, Syvänen S, Zetterberg H, Blennow K, Hanrieder J

Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Aβ Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.

J Neurochem. 2019 Oct 12; PubMed: 31605538

PAPER Chen HJ, Topp SD, Hui HS, Zacco E, Katarya M, McLoughlin C, King A, Smith BN, Troakes C, Pastore A, Shaw CE

RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.

Brain. 2019 Oct 11; PubMed: 31605140